Overview
No overview information available.
Indication
⑴用于治疗成人和儿童腹泻，及肠道菌群失调所引起的腹泻症状。⑵预防和治疗由抗菌素诱发的结肠炎和腹泻。⑶与万古霉素或甲硝唑联合治疗梭状芽胞杆菌所致顽固性疾病的复发。⑷预防由管饲等引起的腹泻。⑸治疗肠易激综合征。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/10 | Not Applicable | Not yet recruiting | Zhongda Hospital | ||
2024/08/06 | Not Applicable | Completed | |||
2019/06/25 | Phase 4 | UNKNOWN | Clinical Centre of Serbia | ||
2018/10/02 | Phase 4 | Completed | Coordinación de Investigación en Salud, Mexico | ||
2018/09/28 | Not Applicable | Completed | |||
2015/12/22 | Phase 2 | UNKNOWN | Oslo University Hospital | ||
2013/01/08 | Phase 2 | Completed | Federal University of Minas Gerais | ||
2011/12/28 | Phase 2 | Completed | |||
2011/03/15 | Phase 3 | UNKNOWN | Zekai Tahir Burak Women's Health Research and Education Hospital | ||
2010/06/14 | Phase 3 | Terminated | Bernhard Nocht Institute for Tropical Medicine |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| ULTRA-LEVURA 50 MG CAPSULAS DURAS | Petsiavas S.A. Industrial And Commercial Enterprises | 46177-19-6-2013 | CÁPSULA DURA | Sin Receta | Commercialized |
| ULTRA LEVURA CAPSULAS | 311001-9 | CÁPSULA DURA | Sin Receta | Commercialized | |
| ULTRA-LEVURA 50 MG CAPSULAS DURAS | Petsiavas S.A. Industrial And Commercial Enterprises | 46177-19-6-2013IP | CÁPSULA DURA | Sin Receta | Not Commercialized |
| ULTRA LEVURA 50 MG CAPSULAS DURAS | 34009325988541 | CÁPSULA DURA | Sin Receta | Not Commercialized | |
| ULTRA-LEVURA 250 MG CAPSULAS DURAS | Petsiavas S.A. Industrial And Commercial Enterprises | 0697702 | CÁPSULA DURA | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.